- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Fleury SA (FLRY3)
Fleury SA stock price live, this page displays BVMF FLRY3 stock exchange data. View the FLRY3 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Fleury SA real time stock price chart below.
What Is the Fleury SA Stock Price Today?
The Fleury SA stock price today is 14.24.
What Is the Stock Symbol for Fleury SA?
The stock symbol for Fleury SA is ""FLRY3.""
What Stock Exchange Does Fleury SA Trade On?
Fleury SA is listed and trades on the B3 stock exchange.
Is Fleury SA a Good Stock to Buy?
Determining whether Fleury SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the FLRY3 quote. (ISIN: BRFLRYACNOR5)
What Is the Fleury SA Stock Price Today?
The Fleury SA stock price today is 14.24.
What Is the Stock Symbol for Fleury SA?
The stock symbol for Fleury SA is ""FLRY3.""
What Stock Exchange Does Fleury SA Trade On?
Fleury SA is listed and trades on the B3 stock exchange.
Is Fleury SA a Good Stock to Buy?
Determining whether Fleury SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the FLRY3 quote. (ISIN: BRFLRYACNOR5)
B3
Currency in BRL
14.24
-0.06(-0.42%)
Delayed Data·
Fair Value
An estimate of a FLEURY ON's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
14.14
14.41
52 wk Range
10.62
16.60
FLRY3 Scorecard
Full Analysis
2 analysts have revised their earnings downwards for the upcoming period
FLRY3 is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a FLEURY ON's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
14.1414.41
52 wk Range
10.6216.60
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.26%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.26%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
FLRY3 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a FLEURY ON's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
15.09
Upside
+5.98%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
- Fleury SA receives Investment Bank Analyst Rating Update
- Investing.com
Pro - FLEURY ON NM receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Fleury SA receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- FLEURY ON NM receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Fleury SA receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Fleury SA receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Fleury SA receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy
Fleury SA Company Profile
Fleury S.A., together with its subsidiaries, provides medical services in the diagnostic, treatment, clinical analysis, health management, medical care, orthopedics, and ophthalmology areas in Brazil. The company operates through three segments: Diagnostic Medicine, Integrated Medicine, and Dental. It provides laboratory and imaging tests, genomics, health management and platform, diagnostic information, check-up and reference laboratory, clinic day, infusion center, orthopedics and ophthalmology, dental imaging tests, and diagnostic imaging services. The company also offers Saúde I, a digital healthcare platform that provides services, including scheduling and performing teleconsultations, and face-to-face consultations, as well as scheduling and accessing diagnostic test results, electronic medical record, and self-manage health issues. It operates customer service units and hospital-based units under the Fleury, Felippe Mattoso, Labs a+, Diagnoson a+, Papaiz, Serdil, LAFE, Instituto de Radiologia de Natal, Centro de Patologia Clínica, Diagmax, Santécorp, a+SP, CIP, Saha, Moacir Cunha, Vita, e Campana, Methodos, Pretti, Bioclinico, a+PE, Marcelo Magalhaes, Inlab, Weinmann, a+, a+BA, IRN, CPC, and a+PI brand names. The company was founded in 1926 and is headquartered in São Paulo, Brazil.
Compare FLRY3 to Peers and Sector
Metrics to compare | FLRY3 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipFLRY3PeersSector | |
|---|---|---|---|---|
P/E Ratio | 12.2x | 16.3x | −0.5x | |
PEG Ratio | 0.58 | 0.29 | 0.00 | |
Price/Book | 1.5x | 1.1x | 2.6x | |
Price / LTM Sales | 1.0x | 0.9x | 3.3x | |
Upside (Analyst Target) | 4.9% | 19.3% | 43.5% | |
Fair Value Upside | Unlock | 22.2% | 6.3% | Unlock |
Analyst Ratings
4 Buy
5 Hold
2 Sell
Ratings:
11 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 15.09
(+5.98% Upside)
Earnings
Latest Release
May 08, 2025
EPS / Forecast
0.329 / 0.34
Revenue / Forecast
2.02B / 2.03B
People Also Watch
FAQ
What Stock Exchange Does FLEURY ON Trade On?
FLEURY ON is listed and trades on the B3 Stock Exchange stock exchange.
What Is the Stock Symbol for FLEURY ON?
The stock symbol for FLEURY ON is "FLRY3."
What Is the FLEURY ON Market Cap?
As of today, FLEURY ON market cap is 7.76B.
What Is FLEURY ON's Earnings Per Share (TTM)?
The FLEURY ON EPS (TTM) is 1.15.
When Is the Next FLEURY ON Earnings Date?
FLEURY ON will release its next earnings report on 06 Aug 2025.
From a Technical Analysis Perspective, Is FLRY3 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has FLEURY ON Stock Split?
FLEURY ON has split 2 times.
How Many Employees Does FLEURY ON Have?
FLEURY ON has 27500 employees.
What is the current trading status of FLEURY ON (FLRY3)?
As of 05 Aug 2025, FLEURY ON (FLRY3) is trading at a price of 14.24, with a previous close of 14.30. The stock has fluctuated within a day range of 14.14 to 14.41, while its 52-week range spans from 10.62 to 16.60.
What Is FLEURY ON (FLRY3) Price Target According to Analysts?
The average 12-month price target for FLEURY ON is BRL15.09091, with a high estimate of BRL19.5 and a low estimate of BRL11.5. 4 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Neutral. The stock has an +5.98% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.